A Dark Vector Cognition product

Item 16. Form 10-K Summary

2K characters. Original on sec.gov ·

Item 16. Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

March 1, 2017

BUILDERS FIRSTSOURCE, INC.
/s/ FLOYD F. SHERMAN
Floyd F. Sherman
Chief Executive Officer
(Principal Executive Officer)

The undersigned hereby constitute and appoint Donald F. McAleenan and his substitutes our true and lawful attorneys-in-fact with full power to execute in our name and behalf in the capacities indicated below any and all amendments to this report and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, and hereby ratify and confirm all that such attorney-in-fact or his substitutes shall lawfully do or cause to be done by virtue thereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureTitleDate
/s/ FLOYD F. SHERMANChief Executive Officer and DirectorMarch 1, 2017
Floyd F. Sherman(Principal Executive Officer)
/s/ PETER M. JACKSONSenior Vice President and Chief Financial OfficerMarch 1, 2017
Peter M. Jackson(Principal Financial Officer)
/s/ JAMI COULTERVice President and Chief Accounting OfficerMarch 1, 2017
Jami Coulter(Principal Accounting Officer)
/s/ PAUL S. LEVYChairman and DirectorMarch 1, 2017
Paul S. Levy
/s/ CLEVELAND A. CHRISTOPHEDirectorMarch 1, 2017
Cleveland A. Christophe
/s/ DANIEL AGROSKINDirectorMarch 1, 2017
Daniel Agroskin
/s/ ROBERT C. GRIFFINDirectorMarch 1, 2017
Robert C. Griffin
/s/ KEVIN J. KRUSEDirectorMarch 1, 2017
Kevin J. Kruse
/s/ BRETT N. MILGRIMDirectorMarch 1, 2017
Brett N. Milgrim
/s/ CRAIG A. STEINKEDirectorMarch 1, 2017
Craig A. Steinke

Previous: Item 15. Exhibits and Financial Statement Schedules